The trademark application ADHUMA was filed by TEVA PHARMACEUTICALS USA, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 11, 2023, and it was registered by office on August 18, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders and pharmaceutical preparations for use in hematology..